Scientific paper - Original scientific paper
A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies
Pharmaceutics, 13 (2021), 6; 795. https://doi.org/10.3390/pharmaceutics13060795


Cite this document

Nižić Nodilo, L., Ugrina, I., Špoljarić, D., Amidžić Klarić, D., Jakobušić Brala, C., Perkušić, M. ... Hafner, A. (2021). A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies. Pharmaceutics, 13. (6). doi: 10.3390/pharmaceutics13060795

Nižić Nodilo, Laura, et al. "A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies." Pharmaceutics, vol. 13, no. 6, 2021. https://doi.org/10.3390/pharmaceutics13060795

Nižić Nodilo, Laura, Ivo Ugrina, Drago Špoljarić, Daniela Amidžić Klarić, Cvijeta Jakobušić Brala, Mirna Perkušić, Ivan Pepić, et al. "A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies." Pharmaceutics 13, no. 6 (2021). https://doi.org/10.3390/pharmaceutics13060795

Nižić Nodilo, L., et al. (2021) 'A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies', Pharmaceutics, 13(6). doi: 10.3390/pharmaceutics13060795

Nižić Nodilo L, Ugrina I, Špoljarić D, Amidžić Klarić D, Jakobušić Brala C, Perkušić M, and sur.. A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies. Pharmaceutics [Internet]. 2021 May 26 [cited 2024 April 12];13(6). doi: 10.3390/pharmaceutics13060795

L. Nižić Nodilo, et al., "A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies", Pharmaceutics, vol. 13, no. 6, May 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:605462. [Accessed: 12 April 2024]

Please login to the repository to save this object to your list.